Full article: Efficacy and safety of cyclin dependent kinases 4/6 inhibitors in the treatment of metastatic breast cancer: a real-world experience
![IJMS | Free Full-Text | Currently Applied Molecular Assays for Identifying ESR1 Mutations in Patients with Advanced Breast Cancer | HTML IJMS | Free Full-Text | Currently Applied Molecular Assays for Identifying ESR1 Mutations in Patients with Advanced Breast Cancer | HTML](https://www.mdpi.com/ijms/ijms-21-08807/article_deploy/html/images/ijms-21-08807-g001.png)
IJMS | Free Full-Text | Currently Applied Molecular Assays for Identifying ESR1 Mutations in Patients with Advanced Breast Cancer | HTML
![Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing | Nature Communications Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-19342-3/MediaObjects/41467_2020_19342_Fig1_HTML.png)
Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing | Nature Communications
![Astragaloside regulates lncRNA LOC100912373 and the miR‑17‑5p/PDK1 axis to inhibit the proliferation of fibroblast‑like synoviocytes in rats with rheumatoid arthritis Astragaloside regulates lncRNA LOC100912373 and the miR‑17‑5p/PDK1 axis to inhibit the proliferation of fibroblast‑like synoviocytes in rats with rheumatoid arthritis](https://www.spandidos-publications.com/article_images/ijmm/48/1/IJMM-48-01-04963-g01.jpg)
Astragaloside regulates lncRNA LOC100912373 and the miR‑17‑5p/PDK1 axis to inhibit the proliferation of fibroblast‑like synoviocytes in rats with rheumatoid arthritis
![Understanding flow chemistry for the production of active pharmaceutical ingredients - ScienceDirect Understanding flow chemistry for the production of active pharmaceutical ingredients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589004222001626-gr7.jpg)
Understanding flow chemistry for the production of active pharmaceutical ingredients - ScienceDirect
![Comprehensive characterization of protein–protein interactions perturbed by disease mutations | Nature Genetics Comprehensive characterization of protein–protein interactions perturbed by disease mutations | Nature Genetics](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41588-020-00774-y/MediaObjects/41588_2020_774_Fig1_HTML.png)
Comprehensive characterization of protein–protein interactions perturbed by disease mutations | Nature Genetics
![Women with short survival after diagnosis of metastatic breast cancer: a population-based registry study | SpringerLink Women with short survival after diagnosis of metastatic breast cancer: a population-based registry study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10549-022-06591-7/MediaObjects/10549_2022_6591_Fig2_HTML.png)
Women with short survival after diagnosis of metastatic breast cancer: a population-based registry study | SpringerLink
![Kisqali® (ribociclib) for the Treatment of HR+/HER2- Metastatic Breast Cancer - Clinical Trials Arena Kisqali® (ribociclib) for the Treatment of HR+/HER2- Metastatic Breast Cancer - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2019/07/3l-image-140.jpg)
Kisqali® (ribociclib) for the Treatment of HR+/HER2- Metastatic Breast Cancer - Clinical Trials Arena
![Melissa Jane Fullwood's research works | National University of Singapore, Singapore (NUS) and other places Melissa Jane Fullwood's research works | National University of Singapore, Singapore (NUS) and other places](https://www.researchgate.net/publication/361240251/figure/tbl1/AS:1179021031276571@1658111927833/Targets-and-their-potential-inhibitors-of-disrupting-SE-components_Q320.jpg)
Melissa Jane Fullwood's research works | National University of Singapore, Singapore (NUS) and other places
![PROTACs: great opportunities for academia and industry (an update from 2020 to 2021) | Signal Transduction and Targeted Therapy PROTACs: great opportunities for academia and industry (an update from 2020 to 2021) | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-022-00999-9/MediaObjects/41392_2022_999_Fig3_HTML.png)
PROTACs: great opportunities for academia and industry (an update from 2020 to 2021) | Signal Transduction and Targeted Therapy
![3d Struktura Ribociclib, Lek Który Jest Inhibitorem Cycli Ilustracji - Ilustracja złożonej z substancja, realistyczny: 84012085 3d Struktura Ribociclib, Lek Który Jest Inhibitorem Cycli Ilustracji - Ilustracja złożonej z substancja, realistyczny: 84012085](https://thumbs.dreamstime.com/z/d-struktura-ribociclib-lek-kt%C3%B3ry-jest-inhibitorem-cycli-84012085.jpg)
3d Struktura Ribociclib, Lek Który Jest Inhibitorem Cycli Ilustracji - Ilustracja złożonej z substancja, realistyczny: 84012085
![Cancers | Free Full-Text | PARP Inhibitors: A Major Therapeutic Option in Endocrine-Receptor Positive Breast Cancers | HTML Cancers | Free Full-Text | PARP Inhibitors: A Major Therapeutic Option in Endocrine-Receptor Positive Breast Cancers | HTML](https://www.mdpi.com/cancers/cancers-14-00599/article_deploy/html/images/cancers-14-00599-g001.png)
Cancers | Free Full-Text | PARP Inhibitors: A Major Therapeutic Option in Endocrine-Receptor Positive Breast Cancers | HTML
![PDF) Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials PDF) Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials](https://i1.rgstatic.net/publication/330484105_Comparative_efficacy_of_palbociclib_ribociclib_and_abemaciclib_for_ER_metastatic_breast_cancer_an_adjusted_indirect_analysis_of_randomized_controlled_trials/links/5cccb6cc92851c4eab80ffb1/largepreview.png)
PDF) Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials
![Cancers | Free Full-Text | Development and Validation of Targeted Gene Sequencing Panel Based Companion Diagnostic for Korean Patients with Solid Tumors | HTML Cancers | Free Full-Text | Development and Validation of Targeted Gene Sequencing Panel Based Companion Diagnostic for Korean Patients with Solid Tumors | HTML](https://www.mdpi.com/cancers/cancers-13-05112/article_deploy/html/images/cancers-13-05112-g001.png)
Cancers | Free Full-Text | Development and Validation of Targeted Gene Sequencing Panel Based Companion Diagnostic for Korean Patients with Solid Tumors | HTML
![Multistep Continuous-Flow Processes for the Preparation of Heterocyclic Active Pharmaceutical Ingredients | SpringerLink Multistep Continuous-Flow Processes for the Preparation of Heterocyclic Active Pharmaceutical Ingredients | SpringerLink](https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F7081_2018_21/MediaObjects/448757_1_En_21_Fig10_HTML.png)